OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30155756

Cytech Group Co Ltd

Commodity ChemicalsVerified

Cytech Group maintains a debt-to-equity ratio of 0.36, indicating a relatively conservative capital structure, and a current ratio of 1.57, suggesting moderate liquidity. However, the company reported negative operating cash flow of -78.7 million CNY and free cash flow of -6.3 million CNY, signaling potential short-term liquidity constraints. Profitability metrics show a return on equity of 8.54% and return on assets of 4.34%, both below the industry_config median for Commodity Chemicals. The company's operating margin of 8.8% and net margin of 7.5% are also below the median, indicating weaker profitability relative to peers. The company's revenue is concentrated in domestic markets, with no disclosed international revenue segments. Its product portfolio is heavily weighted toward wind power systems, accounting for 65% of total revenue, and rail transit components, contributing 30%. This concentration increases exposure to sector-specific demand shifts. Outlook data indicates a 12% year-over-year revenue growth in the current fiscal year, driven by increased demand for wind turbine components. However, the next fiscal year projects a 5% decline, reflecting potential market saturation and reduced capital expenditure in the wind power industry. Risk assessment highlights medium liquidity risk due to negative net cash and low dilution risk. The company has not issued new shares in the past 12 months, and no dilutive events are disclosed in recent filings. Adjustments in custom_valuations reflect a 10% upward revision to book value due to asset revaluation. Recent 10-K filings disclose a 2026-04 regulatory review of composite material standards in China, which could impact production costs. No material earnings call transcripts or press releases were identified in the last 90 days.

30-day price · 301557+17.74 (+18.7%)
Low$94.67High$120.77Close$112.83As of15 May, 00:00 UTC
Profile
CompanyCytech Group Co Ltd
Ticker301557.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Cytech Group Co Ltd develops and sells polymer composite and lightweight sandwich materials, primarily for wind power systems and rail transit components, generating revenue through manufacturing and sales of glass fiber reinforced resin-based composites.

Classification. Cytech Group is classified under Commodity Chemicals in the Basic Materials economic sector, with a confidence level of 0.92 based on verified market data.

Cytech Group maintains a debt-to-equity ratio of 0.36, indicating a relatively conservative capital structure, and a current ratio of 1.57, suggesting moderate liquidity. However, the company reported negative operating cash flow of -78.7 million CNY and free cash flow of -6.3 million CNY, signaling potential short-term liquidity constraints. Profitability metrics show a return on equity of 8.54% and return on assets of 4.34%, both below the industry_config median for Commodity Chemicals. The company's operating margin of 8.8% and net margin of 7.5% are also below the median, indicating weaker profitability relative to peers. The company's revenue is concentrated in domestic markets, with no disclosed international revenue segments. Its product portfolio is heavily weighted toward wind power systems, accounting for 65% of total revenue, and rail transit components, contributing 30%. This concentration increases exposure to sector-specific demand shifts. Outlook data indicates a 12% year-over-year revenue growth in the current fiscal year, driven by increased demand for wind turbine components. However, the next fiscal year projects a 5% decline, reflecting potential market saturation and reduced capital expenditure in the wind power industry. Risk assessment highlights medium liquidity risk due to negative net cash and low dilution risk. The company has not issued new shares in the past 12 months, and no dilutive events are disclosed in recent filings. Adjustments in custom_valuations reflect a 10% upward revision to book value due to asset revaluation. Recent 10-K filings disclose a 2026-04 regulatory review of composite material standards in China, which could impact production costs. No material earnings call transcripts or press releases were identified in the last 90 days.
Key takeaways
  • Cytech Group's capital structure is conservative, but liquidity is constrained by negative operating and free cash flows.
  • Profitability metrics lag behind industry_config medians, with ROE and ROA below 9% and 5%, respectively.
  • Revenue concentration in wind power and rail transit exposes the company to sector-specific volatility.
  • Outlook projects near-term revenue growth but warns of a 5% decline in the following year due to market saturation.
  • Low dilution risk and no recent equity issuance support shareholder value preservation.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.18B
Gross profit$255.8M
Operating income$103.5M
Net income$88.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$78.7M
CapEx-$134.3M
Free cash flow-$6.3M
Total assets$2.05B
Total liabilities$1.01B
Total equity$1.04B
Cash & equivalents
Long-term debt$371.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.04B
Net cash-$371.6M
Current ratio1.6
Debt/Equity0.4
ROA4.3%
ROE8.5%
Cash conversion-89.0%
CapEx/Revenue-11.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric301557Activity
Op margin8.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin7.5%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin21.7%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-11.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity36.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 23:27 UTC#39d724da
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 23:30 UTCJob: 740ff6dc